Company Overview
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugate therapies. Our pipeline includes varegacestat, a late-clinical stage GSI; IM-1021, a clinical-stage ROR1 ADC; and IM-3050, a FAP-targeted radiotherapy that recently received IND clearance. We are also advancing a broad portfolio of early stage ADCs pursuing undisclosed solid tumor targets.
Position Overview
The Contract Senior Recruiter, Life Sciences will support Immunome’s growing clinical and development organization by leading full-cycle recruitment for a broad range of roles across the organization. This position will partner closely with a variety of teams to attract, assess, and hire high-quality talent in a competitive oncology biotech environment. Deep experience in sourcing and recruiting in two or more areas is required: Clinical Research, Translational Medicine, Biometrics, Clinical Operations, Clinical Development, Technical Operations. This is an hourly, contract role. We anticipate 30-40 hours of work for a six month contract period of time.
Responsibilities
- Lead full-cycle recruitment for a variety of clinical and development-focused roles, including sourcing, screening, interviewing, and offer coordination.
- Partner closely with hiring managers and HR to understand evolving business needs, role requirements, and hiring priorities.
- Develop and execute proactive sourcing strategies to identify qualified candidates with experience in oncology drug development and clinical research environments.
- Conduct in-depth candidate interviews to assess technical qualifications, cultural fit, and alignment with Immunome’s values.
- Coordinate interview logistics, gather feedback, and facilitate timely hiring decisions.
- Ensure a high-quality and consistent candidate experience throughout the recruitment process.
- Maintain accurate and compliant records within the applicant tracking system.
- Provide market insights related to talent availability, compensation trends, and competitive intelligence.
- Support contract and contingent workforce hiring needs as required.
Qualifications
- Bachelor’s degree or equivalent combination of education and experience.
- A minimum of 7 years of full-cycle recruiting experience.
- Demonstrated experience recruiting clinical, or development-focused roles within biotech, pharmaceutical, or CRO environments.
- Experience supporting contract-based and contingent hiring models.
- Proven ability to manage multiple requisitions in a fast-paced, high-growth environment.
- Ability to work on-site in Bothell a minimum of one day per week.
Knowledge and Skills
- Strong understanding of research, clinical research, clinical development, and drug development functions within an oncology-focused organization, preferred.
- Experienced utilizing a variety of candidate sourcing tools and platforms.
- Excellent interpersonal, communication, and stakeholder management skills.
- Strong organizational skills with a high attention to detail.
- Ability to work independently while collaborating effectively across cross-functional teams.
E/E/O
Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
E-Verify
Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish).
Similar Jobs
What We Do
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.
